Mia Furebring
Researcher at Department of Medical Sciences; Infection medicine
- Telephone:
- +46 18 611 54 88
- E-mail:
- Mia.Furebring@medsci.uu.se
- Visiting address:
- Akademiska sjukhuset
Infektion, ingång 34, 1 tr - Postal address:
- Akademiska sjukhuset
Infektion, ingång 34, 1 tr
751 85 Uppsala
Download contact information for Mia Furebring at Department of Medical Sciences; Infection medicine
Publications
Recent publications
-
Part of The Lancet Microbe, 2025
- DOI for Prevalence, misclassification, and clinical consequences of the heteroresistant phenotype in Escherichia coli bloodstream infections in patients in Uppsala, Sweden: a retrospective cohort study
- Download full text (pdf) of Prevalence, misclassification, and clinical consequences of the heteroresistant phenotype in Escherichia coli bloodstream infections in patients in Uppsala, Sweden: a retrospective cohort study
-
Heteroresistance and clinical outcomes: much still to be understood – Authors' reply
Part of The Lancet Microbe, 2025
- DOI for Heteroresistance and clinical outcomes: much still to be understood – Authors' reply
- Download full text (pdf) of Heteroresistance and clinical outcomes: much still to be understood – Authors' reply
-
Part of Journal of Antimicrobial Chemotherapy, p. 876-884, 2025
- DOI for Short, extended and continuous infusion of β-lactams: predicted impact on target attainment and risk for toxicity in an ICU patient cohort
- Download full text (pdf) of Short, extended and continuous infusion of β-lactams: predicted impact on target attainment and risk for toxicity in an ICU patient cohort
-
Part of Scientific Reports, 2025
- DOI for Utilizing gentamicin concentrations to estimate glomerular filtration rate in intensive care unit patients
- Download full text (pdf) of Utilizing gentamicin concentrations to estimate glomerular filtration rate in intensive care unit patients
-
Part of International Journal of Clinical Pharmacy, p. 178-186, 2025
- DOI for Model-informed precision dosing of vancomycin in clinical practice: an intervention development study
- Download full text (pdf) of Model-informed precision dosing of vancomycin in clinical practice: an intervention development study
All publications
Articles in journal
-
Heteroresistance and clinical outcomes: much still to be understood – Authors' reply
Part of The Lancet Microbe, 2025
- DOI for Heteroresistance and clinical outcomes: much still to be understood – Authors' reply
- Download full text (pdf) of Heteroresistance and clinical outcomes: much still to be understood – Authors' reply
-
Part of Journal of Antimicrobial Chemotherapy, p. 876-884, 2025
- DOI for Short, extended and continuous infusion of β-lactams: predicted impact on target attainment and risk for toxicity in an ICU patient cohort
- Download full text (pdf) of Short, extended and continuous infusion of β-lactams: predicted impact on target attainment and risk for toxicity in an ICU patient cohort
-
Part of Scientific Reports, 2025
- DOI for Utilizing gentamicin concentrations to estimate glomerular filtration rate in intensive care unit patients
- Download full text (pdf) of Utilizing gentamicin concentrations to estimate glomerular filtration rate in intensive care unit patients
-
Part of International Journal of Clinical Pharmacy, p. 178-186, 2025
- DOI for Model-informed precision dosing of vancomycin in clinical practice: an intervention development study
- Download full text (pdf) of Model-informed precision dosing of vancomycin in clinical practice: an intervention development study
-
Nya rekommendationer för infusion av betalaktamantibiotika
Part of Läkartidningen, 2024
-
Part of European Journal of Vascular and Endovascular Surgery, p. 397-406, 2023
- DOI for Semi-Conservative Treatment Versus Radical Surgery in Abdominal Aortic Graft and Endograft Infections
- Download full text (pdf) of Semi-Conservative Treatment Versus Radical Surgery in Abdominal Aortic Graft and Endograft Infections
-
Part of Journal of Antimicrobial Chemotherapy, p. 2895-2901, 2023
- DOI for Swedish multicentre study of target attainments with β-lactams in the ICU: which MIC parameter should be used?
- Download full text (pdf) of Swedish multicentre study of target attainments with β-lactams in the ICU: which MIC parameter should be used?
-
Invasive fungal infection by Peziza ostracoderma in an immunocompromised patient
Part of Medical Mycology Case Reports, p. 26-30, 2023
- DOI for Invasive fungal infection by Peziza ostracoderma in an immunocompromised patient
- Download full text (pdf) of Invasive fungal infection by Peziza ostracoderma in an immunocompromised patient
-
The Microbiology of Infective Native Aortic Aneurysms in a Population-Based Setting
Part of Annals of Vascular Surgery, p. 112-122, 2022
-
Part of Scientific Reports, 2022
- DOI for Low attainment to PK/PD-targets for β-lactams in a multi-center study on the first 72 h of treatment in ICU patients
- Download full text (pdf) of Low attainment to PK/PD-targets for β-lactams in a multi-center study on the first 72 h of treatment in ICU patients
-
Part of Biomedicines, 2022
- DOI for Urine Hydrogen Peroxide Levels and Their Relation to Outcome in Patients with Sepsis, Septic Shock, and Major Burn Injury
- Download full text (pdf) of Urine Hydrogen Peroxide Levels and Their Relation to Outcome in Patients with Sepsis, Septic Shock, and Major Burn Injury
-
Population pharmacokinetics of cefotaxime in intensive care patients
Part of European Journal of Clinical Pharmacology, p. 251-258, 2022
- DOI for Population pharmacokinetics of cefotaxime in intensive care patients
- Download full text (pdf) of Population pharmacokinetics of cefotaxime in intensive care patients
-
Part of Mycoses, p. 79-87, 2022
- DOI for Human plasma protein levels alter the in vitro antifungal activity of caspofungin: An explanation to the effect in critically ill?
- Download full text (pdf) of Human plasma protein levels alter the in vitro antifungal activity of caspofungin: An explanation to the effect in critically ill?
-
Part of European Journal of Vascular and Endovascular Surgery, p. 918-926, 2021
- DOI for Outcome of Radical Surgical Treatment of Abdominal Aortic Graft and Endograft Infections Comparing Extra-anatomic Bypass with In Situ Reconstruction: A Nationwide Multicentre Study
- Download full text (pdf) of Outcome of Radical Surgical Treatment of Abdominal Aortic Graft and Endograft Infections Comparing Extra-anatomic Bypass with In Situ Reconstruction: A Nationwide Multicentre Study
-
Part of Journal of Endovascular Therapy, p. 328-333, 2020
-
Part of Antimicrobial Agents and Chemotherapy, 2019
-
Part of Clinical Infectious Diseases, p. 480-482, 2018
-
Part of Mycoses, p. 225-225, 2017
-
Part of Circulation, p. 1822-1832, 2016
-
Part of Läkartidningen, 2015
-
Aortagraftinfektion – ett komplicerat kärlkirurgiskt tillstånd
Part of Svensk Kirurgi, p. 84-88, 2013
-
Part of Upsala Journal of Medical Sciences, p. 39-46, 2011
-
Part of Läkartidningen, p. 279-281, 2011
-
Part of Läkartidningen, p. 271-275, 2011
-
Neurointensive care of patients with severe community-acquired meningitis
Part of Acta Anaesthesiologica Scandinavica, p. 732-739, 2011
-
Part of Journal of Clinical Epidemiology, p. 155-162, 2007
-
Part of Scand J Immunol, p. 208-16, 2006
-
Part of British Journal of Haematology, p. 666-673, 2004
-
Part of Scandinavian Journal of Immunology, p. 494-499, 2004
-
Expression of the C5a receptor (CD88) on granulocytes and monocytes in patients with severe sepsis
Part of Critical Care, p. 363-370, 2002
Articles, review/survey
-
Part of Scandinavian journal of infectious diseases, p. 161-175, 2013
Manuscripts (preprints)
Other
-
Part of The Lancet Microbe, 2025
- DOI for Prevalence, misclassification, and clinical consequences of the heteroresistant phenotype in Escherichia coli bloodstream infections in patients in Uppsala, Sweden: a retrospective cohort study
- Download full text (pdf) of Prevalence, misclassification, and clinical consequences of the heteroresistant phenotype in Escherichia coli bloodstream infections in patients in Uppsala, Sweden: a retrospective cohort study